Skip to main content
. 2020 Sep 14;29(9):1184–1191. doi: 10.1089/jwh.2020.8291

FIG. 2.

FIG. 2.

Chronic pelvic pain, dysmenorrhea, and dyspareunia of women with endometriosis-associated pain symptoms at baseline and at 3 and 6 months of 24/4 regimen 17β-estradiol (1.5 mg) and NOMAC (2.5 mg) combined oral contraceptive (study group) and of women using on-demand NSAIDs (control group).